Professor Norman Fenton
Posted inCredentialed Experts

Professor Norman Fenton

Norman Fenton is Professor of Risk and Information Management at Queen Mary University of London and is also a Director of Agena, a company that specialises in risk assessment for critical systems.  Norman is a mathematician by training whose current…
10 August 2022Posted inCredentialed Experts
Prof Sucharit Bhakdi
Posted inCredentialed Experts

Prof. Sucharit Bhakdi

Professsor Sucharit Bhakdi MD is a retired Professor Emeritus of Medical Microbiology and Immunology, Former Chair, Institute of Medical Microbiology and Hygiene, Johannes Gutenberg University of Mainz. Sucharit Bhakdi was born in Washington, DC, and educated at schools in Switzerland,…
8 August 2022Posted inCredentialed Experts
Dr Clare Craig
Posted inCredentialed Experts

Dr Clare Craig

Dr Clare Craig BM BCh FRCPath is a medical doctor and is a specialist Diagnostic Pathologist from England. She is a co-chair of the HART Group. Dr Craig is a consultant pathologist who worked for many years with in the…
8 August 2022Posted inCredentialed Experts
Dr Jessica Rose
Posted inCredentialed Experts

Dr Jessica Rose

Dr Jessica Rose, PhD, MSc, BSc, is a Canadian researcher with a Bachelor's Degree in Applied Mathematics and a Master's degree in Immunology from Memorial University of Newfoundland. She also holds a PhD in Computational Biology from Bar Ilan University…
6 August 2022Posted inCredentialed Experts
Janssen/ Johnson & Johnson CV-19
Posted inCOVID-19 Vaccines

Johnson & Johnson

Janssen Pharmaceuticals is a wholly-owned subsidiary of Johnson & Johnson (J&J) and in 2020 they produced a COVID-19 vaccine [Ad26.COV2.S, recombinant] in partnership with Catalent. In June 2020 J&J partnered with the US NIAID/BARDA as part of Operation Warp Speed.…
5 August 2022Posted inCOVID-19 Vaccines
Moderna COVID-19 vaccine
Posted inCOVID-19 Vaccines

Moderna

Moderna, based in Cambridge, Massachusett., began it's inception in 2010 following Derek Rossi's breakthrough paper, demonstrating chemically modified mRNA could reprogram adult human fibroblast cells - the prelude to gene therapy. The main investor in the startup was Flagship Pioneering.…
5 August 2022Posted inCOVID-19 Vaccines
Professor Dolores Cahill
Posted inCredentialed Experts

Professor Dolores Cahill

Professor Dolores J. Cahill, Ph.D. modestly describes herself as a scientist and professor with a background in molecular biology and immunology, but her CV is enormous. She has over twenty years of expertise in “high-throughput protein & antibody array, proteomics…
2 August 2022Posted inCredentialed Experts